Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 82 citing articles:

Anti-Spike Protein Assays to Determine SARS-CoV-2 Antibody Levels: a Head-to-Head Comparison of Five Quantitative Assays
Thomas Perkmann, Nicole Perkmann‐Nagele, Thomas Köller, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 176
Differential Antibody Response to mRNA COVID-19 Vaccines in Healthy Subjects
Sarah Wheeler, Galina V. Shurin, Mary Yost, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 148
Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers
Christian Irsara, Alexander Egger, Wolfgang Prokop, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 8, pp. 1453-1462
Open Access | Times Cited: 65
Point-of-care diagnostics: recent developments in a pandemic age
Harshit Harpaldas, Siddarth Arumugam, Chelsey Campillo Rodriguez, et al.
Lab on a Chip (2021) Vol. 21, Iss. 23, pp. 4517-4548
Open Access | Times Cited: 60
Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
Matthijs Oyaert, Marie‐Angélique De Scheerder, Sophie Van Herrewege, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 53
Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial
Simon Jochum, Imke Kirste, Sayuri Hortsch, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 49
Prior SARS-CoV-2 infection enhances and reshapes spike protein–specific memory induced by vaccination
Véronique Barateau, Loïc Peyrot, Carla Saade, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 687
Open Access | Times Cited: 23
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Elisa Danese, Martina Montagnana, Gian Luca Salvagno, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2021) Vol. 59, Iss. 9, pp. 1585-1591
Open Access | Times Cited: 51
Kinetics and persistence of cellular and humoral immune responses to SARS‐CoV‐2 vaccine in healthcare workers with or without prior COVID‐19
Mihaela Chivu‐Economescu, Coralia Bleoţu, Camelia Grancea, et al.
Journal of Cellular and Molecular Medicine (2022) Vol. 26, Iss. 4, pp. 1293-1305
Open Access | Times Cited: 36
Intensidad y duración de la respuesta inmune humoral a la vacuna para COVID 19 en trabajadores de la salud, utilizando una prueba de anticuerpos IgG cuantitativos
Gabriela Becerra, Sigifredo Ospina, Lisseth Pizano, et al.
Infectio (2025), pp. 16-22
Open Access
SARS-CoV-2 Tests: Bridging the Gap between Laboratory Sensors and Clinical Applications
N. A. Toropov, Eleanor L. Osborne, Lovleen Tina Joshi, et al.
ACS Sensors (2021) Vol. 6, Iss. 8, pp. 2815-2837
Open Access | Times Cited: 35
Evaluation of Commercial Anti-SARS-CoV-2 Antibody Assays and Comparison of Standardized Titers in Vaccinated Health Care Workers
Kahina Saker, Vanessa Escuret, Virginie Pitiot, et al.
Journal of Clinical Microbiology (2021) Vol. 60, Iss. 1
Open Access | Times Cited: 28
SARS-CoV-2-Neutralizing Antibody Response and Correlation of Two Serological Assays with Microneutralization
Amal Souiri, Sanaâ Lemriss, Bouchra El Maliki, et al.
Vaccines (2023) Vol. 11, Iss. 3, pp. 590-590
Open Access | Times Cited: 10
Multi-antigen intranasal vaccine protects against challenge with sarbecoviruses and prevents transmission in hamsters
Ankita Leekha, Arash Saeedi, K M Samiur Rahman Sefat, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Performance Characteristics of the Vidas SARS-CoV-2 IgM and IgG Serological Assays
Nathalie Renard, Soizic Daniel, Nadège Cayet, et al.
Journal of Clinical Microbiology (2021) Vol. 59, Iss. 4
Open Access | Times Cited: 24
Immune Response Post–SARS-CoV-2 mRNA Vaccination in Kidney Transplant Recipients Receiving Belatacept
Johan Noble, Antoine Langello, William Bouchut, et al.
Transplantation (2021) Vol. 105, Iss. 11, pp. e259-e260
Open Access | Times Cited: 23
Serological anti-SARS-CoV-2 neutralizing antibodies association to live virus neutralizing test titers in COVID-19 paucisymptomatic/symptomatic patients and vaccinated subjects
Antonio Cristiano, Marzia Nuccetelli, Massimo Pieri, et al.
International Immunopharmacology (2021) Vol. 101, pp. 108215-108215
Open Access | Times Cited: 23
SARS-CoV-2 antibody profile of naturally infected and vaccinated individuals detected using qualitative, semi-quantitative and multiplex immunoassays
Jamie Meyers, Anne Windau, Christine Schmotzer, et al.
Diagnostic Microbiology and Infectious Disease (2022) Vol. 104, Iss. 4, pp. 115803-115803
Open Access | Times Cited: 18
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects
Kahina Saker, Bruno Pozzetto, Vanessa Escuret, et al.
Journal of Clinical Virology (2022) Vol. 152, pp. 105169-105169
Open Access | Times Cited: 17
High-throughput detection of neutralizing antibodies to SARS-CoV-2 variants using flow cytometry
Xiaohan Zhang, Yajie Wang, Mansheng Li, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 9
The Three Pillars of COVID-19 Convalescent Plasma Therapy
Massimo Franchini, Giancarlo Maria Liumbruno, Giorgio Piacentini, et al.
Life (2021) Vol. 11, Iss. 4, pp. 354-354
Open Access | Times Cited: 20
Evaluation of the correlation between the access SARS‐CoV‐2 IgM and IgG II antibody tests with the SARS‐CoV‐2 surrogate virus neutralization test
Yutaro Kitagawa, Kazuo Imai, Masaru Matsuoka, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 1, pp. 335-341
Open Access | Times Cited: 20
Correlation between In Vitro Neutralization Assay and Serological Tests for Protective Antibodies Detection
Maria A. Bonifacio, Riccardo Laterza, Angela Vinella, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 9566-9566
Open Access | Times Cited: 15
Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles
William Mouton, Guy Oriol, Christelle Compagnon, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 7
Closed Access | Times Cited: 2
Anti-Spike protein assays to determine post-vaccination antibody levels: a head-to-head comparison of five quantitative assays
Thomas Perkmann, Nicole Perkmann‐Nagele, Thomas Köller, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top